Indolent systemic mastocytosis or just 'atypical enterocolic mast cell aggregates'?

被引：0
|
作者：
Edema, U. [1 ]
Fang, Y. [1 ]
Qiang, L. [1 ]
Huang, Y. [1 ]
机构：
[1] Montefiore Med Ctr, Pathol, 111 E 210th St, Bronx, NY 10467 USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2021年 / 156卷
关键词：
D O I：
10.1093/ajcp/aqab191.114
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：S56 / S56
页数：1
相关论文
共 50 条
  • [21] Avapritinib for the Treatment of Indolent Systemic Mastocytosis
    Abdelkader, Samer
    Lam, Weyman
    CLINICAL IMMUNOLOGY, 2023, 250 : 65 - 65
  • [22] Treatment of Indolent and Advanced Systemic Mastocytosis
    Buonomo, Alessandro
    Nucera, Eleonora
    Criscuolo, Marianna
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2022, 14
  • [23] Indolent systemic mastocytosis in a patient with ileocolitis
    Chrysakopoulos, Georgios
    Demonakou, Maria
    Papasavvas, Stelios
    Koutsoumpas, Andreas
    Mylonas, Georgios
    Tzias, Vassilios
    ANNALS OF GASTROENTEROLOGY, 2014, 27 (03): : 270 - 272
  • [24] Efficacy of Omalizumab in Indolent Systemic Mastocytosis
    Slapnicar, Calum
    Trinkaus, Martina
    Hicks, Lisa
    Vadas, Peter
    CASE REPORTS IN HEMATOLOGY, 2019, 2019
  • [25] PORCINE MAST-CELL LEUKEMIA WITH SYSTEMIC MASTOCYTOSIS
    BEANKNUDSEN, DE
    CALDWELL, CW
    WAGNER, JE
    STILLS, HF
    VETERINARY PATHOLOGY, 1989, 26 (01) : 90 - 92
  • [26] Changes in mast cell (MC) numbers and phenotype in patients (pts) with indolent systemic mastocytosis (ISM) treated with avapritinib.
    George, Tracy
    Broesby-Olsen, Sigurd
    Wada, David
    Florell, Scott
    Hartman, Karin
    Siebenhaar, Frank
    Akin, Cem
    Newberry, Kate
    Shi, Hongliang
    Roche, Maria
    Maurer, Marcus
    Elberink, Hanneke Oude
    CANCER RESEARCH, 2021, 81 (13)
  • [27] Progression of Mast Cell Activation Syndrome to Systemic Mastocytosis
    Zhou, X.
    Caponetti, G.
    Johnson, E.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 162 : S90 - S90
  • [28] Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) in patients with indolent systemic mastocytosis
    Taylor, Fiona
    Akin, Cem
    Shields, Alan
    Li, Shirley
    Mar, Brenton
    Oren, Ronny
    McDonald, Jeffrey
    Padilla, Brad
    Lin, Hui-Min
    Green, Tanya
    Lee, Philina
    Siebenhaar, Frank
    QUALITY OF LIFE RESEARCH, 2020, 29 (SUPPL 1) : S102 - S102
  • [29] Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis
    Pardanani, A.
    Chen, D.
    Abdelrahman, R. A.
    Reichard, K. K.
    Zblewski, D.
    Wood, A. J.
    McClure, R. F.
    Butterfield, J. H.
    Hanson, C. A.
    Tefferi, A.
    LEUKEMIA, 2013, 27 (10) : 2091 - 2094
  • [30] Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis
    A Pardanani
    D Chen
    R A Abdelrahman
    K K Reichard
    D Zblewski
    A J Wood
    R F McClure
    J H Butterfield
    C A Hanson
    A Tefferi
    Leukemia, 2013, 27 : 2091 - 2094
12345